Browsing Tag
Thrive
2 posts
Viridian Therapeutics reports 70% durability at one year in Phase 3 THRIVE trial for veligrotug in thyroid eye disease
Viridian's veligrotug maintained a 70% response at 52 weeks in TED patients; BLA filing expected in H2 2025. Find out how this breakthrough could reshape care.
Thrive acquires Longleaf Network to expand cybersecurity and cloud services in North Carolina
Thrive, a leading global technology outsourcing provider specializing in cybersecurity, cloud, and IT managed services, has announced its…